Abstract:What's new Susceptibility genes already associated with nonsyndromic familial nonmedullary thyroid carcinoma (FNMTC) account for only a small portion of the disease's genetic burden. Hence, other predisposing genetic alterations are suspected. Here, the authors applied next‐generation sequencing to analyze cancer‐predisposing genes in probands from families with FNMTC. Analyses uncovered multiple genes relevant to FNMTC etiology, including genes involved in DNA repair, where variants are likely to disturb protein–protein interactions. Moreover, three germline variants were found in DICER1, a gene already incorporated into clinical practice for assessing thyroid neoplasia predisposition. The findings broaden the genetic landscape of FNMTC and cast light on pathways for therapeutic targeting. The genetic basis of nonsyndromic familial nonmedullary thyroid carcinoma (FNMTC) is still poorly understood, as the susceptibility genes identified so far only account for a small percentage of the genetic burden. Recently, germline mutations in DNA repair‐related genes have been reported in cases with thyroid cancer. In order to clarify the genetic basis of FNMTC, 94 genes involved in hereditary cancer predisposition, including DNA repair genes, were analyzed in 48 probands from FNMTC families, through targeted next‐generation sequencing (NGS). Genetic variants were selected upon bioinformatics analysis and in silico studies. Structural modeling and network analysis were also performed. In silico results of NGS data unveiled likely pathogenic germline variants in 15 families with FNMTC, in genes encoding proteins involved in DNA repair (ATM, CHEK2, ERCC2, BRCA2, ERCC4, FANCA, FANCD2, FANCF, and PALB2) and in the DICER1, FLCN, PTCH1, BUB1B, and RHBDF2 genes. Structural modeling predicted that most missense variants resulted in the disruption of networks of interactions between residues, with implications for local secondary and tertiary structure elements. Functional annotation and network analyses showed that the involved DNA repair proteins functionally interact with each other, within the same DNA repair pathway and across different pathways. MAPK activation was a common event in tumor progression. This study supports that rare germline variants in DNA repair genes may be accountable for FNMTC susceptibility, with potential future utility in patients' clinical management, and reinforces the relevance of DICER1 in disease etiology.

Whole Genome Sequencing Prioritizes CHEK2, EWSR1, and TIAM1 as Possible Predisposition Genes for Familial Non-Medullary Thyroid Cancer

Targeted Dna Sequencing Detects Mutations Related to Susceptibility among Familial Non-Medullary Thyroid Cancer

Identification of novel candidate predisposing genes in familial nonmedullary thyroid carcinoma implicating DNA damage repair pathways

CHEK2 germline variants identified in familial non-medullary thyroid cancer lead to impaired protein structure and function

RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma.

Clinically-relevant Germline Variants in Children with Non-Medullary Thyroid Cancer

Whole Exome and Target Sequencing Identifies MAP2K5 As Novel Susceptibility Gene for Familial Non-Medullary Thyroid Carcinoma

Chromosomal localization of mutated genes in non-syndromic familial thyroid cancer

CHEK2 founder variants and thyroid cancer risk

Identification of a Novel Germline PPP4R3A Missense Mutation Asp409Asn on Familial Non-Medullary Thyroid Carcinoma

Studies and Prospects of the Candidate Virulence Gene of Familial Medullary Thyroid Carcinoma

Novel truncating germline variant reinforces TINF2 as a susceptibility gene for familial non-medullary thyroid cancer

Genetic Predisposition to Familial Nonmedullary Thyroid Cancer: An Update of Molecular Findings and State-of-the-Art Studies

Clinical and genetic characterization of cancer patients with multiple germline variants.

Exploring the genetic and epigenetic underpinnings of early-onset cancers: Variant prioritization for long read whole genome sequencing from family cancer pedigrees

Identification of P21 (CDKN1A) Activated Kinase 4 as a susceptibility gene for Familial Non-medullary Thyroid Carcinoma

Genome-wide copy number analysis in a family with p.G533C RET mutation and medullary thyroid carcinoma identified regions potentially associated with a higher predisposition to lymph node metastasis.

Targeted Next-Generation Sequencing in Papillary Thyroid Carcinoma Patients Looking for Germline Variants Predisposing to the Disease.

Presumed Pathogenic Germ Line and Somatic Variants in African American Thyroid Cancer

Familial Multinodular Goiter Syndrome with Papillary Thyroid Carcinomas: Mutational Analysis of the Associated Genes in 5 Cases from 1 Chinese Family.

Whole exome sequencing identifies novel germline variants of SLC15A4 gene as potentially cancer predisposing in familial colorectal cancer